Advertisement

ACS: Many Cancer Patients Face Lasting Financial Difficulties

0

Patients with cancer have higher rates of total collections, medical collections, and bankruptcy

Medicaid Expansion Increases Guideline-Concordant Treatment for Breast Cancer

0

Increase seen in receipt of guideline-concordant treatment for women newly diagnosed with HR-negative, HER2-positive breast cancer

Higher Heathy Eating Index Score Beneficial in Prostate Cancer

0

Higher Healthy Eating Index score linked to significantly lower risk for grade reclassification in men undergoing active surveillance

Protracted Radiation Exposure Linked to Hematologic Cancer Mortality

0

Protracted low-dose exposure to ionizing radiation linked to mortality due to certain hematologic malignancies

FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer

0

Vyloy is the first and only CLDN18.2-targeted therapy approved in the United States

FDA Appoints New Head of Medical Devices

0
By Ernie Mundell HealthDay Reporter WEDNESDAY, Oct. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration announced Tuesday that it has appointed Dr....

No Objective Improvement Seen in Cognitive Function With Exercise During Chemo

0

Significant differences seen in four of six self-reported cognitive function outcomes favoring aerobic exercise initiated with chemo

Computer-Aided Detection Colonoscopies Tied to Improved Adenoma Detection Rate

0

Similar average advanced colorectal neoplasia per colonoscopy seen with CADe-enhanced and conventional colonoscopy

Cancer Detection Recovered Following Pandemic Disruptions

0

However, in 2021, cancer incidence rates remained substantially depressed from expected rates in rural areas

AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine

0

Corneal toxicity not uncommon with MIRV treatment for primary gynecologic malignancies, usually resolves